Evidence map›Paper›PMID 42400027›Full record

ArticleInternational journal of retina and vitreous2026

Acute-onset endophthalmitis following pars plana vitrectomy for symptomatic vitreous opacities: a case series.

Michael Y Zhao, Jin Kyun Oh, Landon J Rohowetz, Marc H Levy, Jody Abrams, Curtis E Margo, Steven Cohen, Jorge Fortun, William E Smiddy, Stephen G Schwartz and 1 more

Abstract read
In one paragraph

Article in International journal of retina and vitreous, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michael Y ZhaoDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Health System, 900 NW 17th St, Miami, FL, 33136, USA.
Jin Kyun OhDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Health System, 900 NW 17th St, Miami, FL, 33136, USA.
Landon J RohowetzDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Health System, 900 NW 17th St, Miami, FL, 33136, USA.
Marc H LevySarasota Retina Institute, Orlando, FL, USA.
Jody AbramsSarasota Retina Institute, Orlando, FL, USA.
Curtis E MargoDepartment of Ophthalmology, Morsani College of Medicine, Tampa, FL, USA.
Steven CohenDepartment of Ophthalmology, Morsani College of Medicine, Tampa, FL, USA.
Jorge FortunDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Health System, 900 NW 17th St, Miami, FL, 33136, USA.
William E SmiddyDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Health System, 900 NW 17th St, Miami, FL, 33136, USA.
Stephen G SchwartzDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Health System, 900 NW 17th St, Miami, FL, 33136, USA.
Harry W FlynnDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Health System, 900 NW 17th St, Miami, FL, 33136, USA. hflynn@med.miami.edu.

Funding

Research to Prevent Blindness GR004596-1
6 · The paper itself

Abstract

backgroundPars plana vitrectomy (PPV) for symptomatic vitreous opacities, commonly referred to as floaterectomy, is an increasingly performed elective procedure that can meaningfully improve quality of life. However, like all intraocular surgery, it carries the risk of endophthalmitis. To our knowledge, only 2 cases of this complication following floaterectomy have previously been reported. The purpose of this study is to report the largest series of acute-onset bacterial endophthalmitis following floaterectomy, characterizing clinical presentation, causative organisms, antibiotic susceptibilities, histopathology, and visual outcomes.

methodsThis was a retrospective, interventional case series conducted at a tertiary referral center. A query of all patients who underwent PPV for vitreous opacities from January 2010 through December 2025 was performed. Patients were included if they developed acute-onset endophthalmitis (within one month of PPV).

resultsFive eyes of 5 patients were included. Two of 394 patients (0.5%) who underwent floaterectomy at our institution developed acute-onset endophthalmitis; 3 additional cases were referred from outside retina specialists. Mean presenting BCVA was 2.1 logMAR (~ 20/2500). Four of 5 vitreous cultures (80%) were positive: 2 gram-positive (Staphylococcus caprae, Staphylococcus lugdunensis) and 2 gram-negative (Pseudomonas aeruginosa, Serratia marcescens). The institutional endophthalmitis rate of 0.5% was not statistically different from published post-PPV rates of 0.16-0.28% (P = 0.13). Visual outcomes were polarized: 3 of 5 eyes (60%) achieved BCVA ≥ 20/80, while 2 of 5 (40%) progressed to no light perception and underwent enucleation, both involving gram-negative organisms. Histopathology in one enucleated eye demonstrated extensive intraocular necrosis and suppurative inflammation.

conclusionsAcute-onset endophthalmitis following floaterectomy is rare, occurring at a rate statistically similar to PPV for other indications. However, given that floaterectomy is elective surgery for a largely benign, non-vision-threatening condition, the harm-to-benefit ratio is inherently less favorable than PPV performed for sight-threatening pathology. Gram-negative infections were associated with catastrophic and irreversible vision loss, including enucleation. These findings underscore the importance of thorough, candid preoperative counseling regarding the risk of severe infectious complications before proceeding with floaterectomy.

Indexed as

Acute-onset endophthalmitisPars plana vitrectomyPatient outcomesVitreous opacities no-light-perception

Identifiers

PMID42400027
PMCPMC13602793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.